Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-18-015762

Chief Medical Officer acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Mortensen Eric R. Chief Medical Officer 2018-03-15 Grant or award +20,000 36,500 D
Derivatives
Mortensen Eric R. Chief Medical Officer 2018-03-15 Grant or award · Stock Option (right to buy) +80,000 80,000 D
Loading xslF345X03/tv488961_4.xml…